These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7486862)

  • 1. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves.
    Shillito P; Molenaar PC; Vincent A; Leys K; Zheng W; van den Berg RJ; Plomp JJ; van Kempen GT; Chauplannaz G; Wintzen AR
    Ann Neurol; 1995 Nov; 38(5):714-22. PubMed ID: 7486862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.
    Kleopa KA; Elman LB; Lang B; Vincent A; Scherer SS
    Brain; 2006 Jun; 129(Pt 6):1570-84. PubMed ID: 16613892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels.
    Krampfl K; Mohammadi B; Buchwald B; Jahn K; Dengler R; Toyka KV; Bufler J
    Muscle Nerve; 2003 Apr; 27(4):435-41. PubMed ID: 12661044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia.
    Tomimitsu H; Arimura K; Nagado T; Watanabe O; Otsuka R; Kurono A; Sonoda Y; Osame M; Kameyama M
    Ann Neurol; 2004 Sep; 56(3):440-4. PubMed ID: 15349875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome).
    Sinha S; Newsom-Davis J; Mills K; Byrne N; Lang B; Vincent A
    Lancet; 1991 Jul; 338(8759):75-7. PubMed ID: 1676468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium current suppression in patients with peripheral nerve hyperexcitability.
    Nagado T; Arimura K; Sonoda Y; Kurono A; Horikiri Y; Kameyama A; Kameyama M; Pongs O; Osame M
    Brain; 1999 Nov; 122 ( Pt 11)():2057-66. PubMed ID: 10545391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia.
    Hart IK; Waters C; Vincent A; Newland C; Beeson D; Pongs O; Morris C; Newsom-Davis J
    Ann Neurol; 1997 Feb; 41(2):238-46. PubMed ID: 9029073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-type voltage-gated K+ currents influence firing properties of isolectin B4-positive but not isolectin B4-negative primary sensory neurons.
    Vydyanathan A; Wu ZZ; Chen SR; Pan HL
    J Neurophysiol; 2005 Jun; 93(6):3401-9. PubMed ID: 15647393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.
    Vernino S; Lennon VA
    Muscle Nerve; 2002 Nov; 26(5):702-7. PubMed ID: 12402293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune-mediated neuromyotonia (Isaacs' syndrome)--clinical aspects and pathomechanism].
    Arimura K; Watanabe O
    Brain Nerve; 2010 Apr; 62(4):401-10. PubMed ID: 20420181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine release at neuromuscular junctions of adult tottering mice is controlled by N-(cav2.2) and R-type (cav2.3) but not L-type (cav1.2) Ca2+ channels.
    Pardo NE; Hajela RK; Atchison WD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1009-20. PubMed ID: 16982704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
    Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
    Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels.
    Bufler J; Pitz R; Czep M; Wick M; Franke C
    Ann Neurol; 1998 Apr; 43(4):458-64. PubMed ID: 9546326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New evidence for a presynaptic action of prednisolone at neuromuscular junctions.
    Dal Belo CA; Leite GB; Fontana MD; Corrado AP; Zanandréa Baso AC; Moreno Serra CS; Oliveira AC; Rodrigues-Simioni L
    Muscle Nerve; 2002 Jul; 26(1):37-43. PubMed ID: 12115947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis.
    Sica RE; Gonzalez Cappa SM; Sanz OP; Mirkin G
    Bull Soc Pathol Exot; 1995 Mar; 88(4):156-63. PubMed ID: 8640077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the venom of the yellow Iranian scorpion Odontobuthus doriae on skeletal muscle preparations in vitro.
    Jalali A; Vatanpour H; Hosseininasab Z; Rowan EG; Harvey AL
    Toxicon; 2007 Dec; 50(8):1019-26. PubMed ID: 17976675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
    Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
    Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired neuromyotonia in childhood: case report and review.
    Gonzalez G; Barros G; Russi ME; Nuñez A; Scavone C
    Pediatr Neurol; 2008 Jan; 38(1):61-3. PubMed ID: 18054698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.